NIMH Code: | D-912 |
Compound Name: | 2-{4-[4-(2-Hydroxyphenyl)piperazin-1-yl]butyl}-4-methyl-1,2,4-triazine-3,5-(2H,4H)-dione |
Alternative Name: | 2-[4-[4-(2-hydroxyphenyl)piperazin-1-yl]butyl]-4-methyl-1,2,4-triazine-3,5-dione |
Abbreviation: | Desmethyl CUMI-101 |
PubChemID: | 59738835 |
CAS: | 903528-73-4 |
Molecular Formula: | C18H25N5O3 |
Biological Activity: | 5-HT1A receptor PET imaging ligand precursor |
References: | Kumar, J. S.; Prabhakaran, J.; Majo, V. J.; Milak, M. S.; Hsiung, S. C.; Tamir, H.; Simpson, N. R.; Van Heertum, R. L.; Mann, J. J.; Parsey, R. V. Eur. J. Nucl. Med. Mol. Imaging 2007, 34, 1050-1060. Kumar, J. S.; Majo, V. J.; Hsiung, S. C.; Milak, M. S.; Liu, K. P.; Tamir, H.; Prabhakaran, J.; Simpson, N. R.; Van Heertum, R. L.; Mann, J. J.; Parsey, R. V. J. Med. Chem. 2006, 49, 125-134. |
Comments: | |
Last Updated 2021-02-19 10:25 AM |
Since 1959, the NIMH Chemical Synthesis and Drug Supply Program has synthesized and distributed novel research chemicals, psychoactive drugs, and compounds that are unavailable from commercial sources to the scientific community working on research relevant to mental health.